Outlook Therapeutics (OTLK) Cash from Investing Activities (QoQ) (2015 - 2019)
Outlook Therapeutics (OTLK) Cash from Investing Activities (QoQ) (2015 - 2019) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Outlook Therapeutics |
63.14 Mn |
55.40 Mn |
-21,888.00 |
| Date | Value |
|---|
| Sep 30, 2019 |
100.00% |
| Jun 30, 2019 |
-200.66% |
| Mar 31, 2019 |
78.79% |
| Dec 31, 2018 |
81.28% |
| Sep 30, 2018 |
-651.56% |
| Jun 30, 2018 |
38.94% |
| Mar 31, 2018 |
74.40% |
| Dec 31, 2017 |
-4,383.50% |
| Sep 30, 2017 |
68.54% |
| Jun 30, 2017 |
-75.18% |
| Mar 31, 2017 |
70.67% |
| Dec 31, 2016 |
54.82% |
| Sep 30, 2016 |
27.42% |
| Jun 30, 2016 |
-1,063.76% |
| Mar 31, 2016 |
112.89% |
| Dec 31, 2015 |
88.94% |
| Sep 30, 2015 |
5.58% |
